Exelixis Stock Shares Owned By Insiders
| EXEL Stock | USD 23.73 0.03 0.13% |
Exelixis fundamentals help investors to digest information that contributes to Exelixis' financial success or failures. It also enables traders to predict the movement of Exelixis Stock. The fundamental analysis module provides a way to measure Exelixis' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Exelixis stock.
Exelixis | Shares Owned By Insiders |
Exelixis Company Shares Owned By Insiders Analysis
Exelixis' Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
More About Shares Owned By Insiders | All Equity Analysis
Insiders Shares | = | Executives Shares | + | Employees |
Current Exelixis Shares Owned By Insiders | 2.23 % |
Most of Exelixis' fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Exelixis is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Exelixis Shares Owned By Insiders Driver Correlations
Understanding the fundamental principles of building solid financial models for Exelixis is extremely important. It helps to project a fair market value of Exelixis Stock properly, considering its historical fundamentals such as Shares Owned By Insiders. Since Exelixis' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Exelixis' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Exelixis' interrelated accounts and indicators.
Click cells to compare fundamentals
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
| Competition |
Based on the latest financial disclosure, 2.23% of Exelixis are shares owned by insiders. This is 85.31% lower than that of the Biotechnology sector and 84.27% lower than that of the Health Care industry. The shares owned by insiders for all United States stocks is 77.9% higher than that of the company.
Exelixis Shares Owned By Insiders Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Exelixis' direct or indirect competition against its Shares Owned By Insiders to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Exelixis could also be used in its relative valuation, which is a method of valuing Exelixis by comparing valuation metrics of similar companies.Exelixis is currently under evaluation in shares owned by insiders category among related companies.
Exelixis Fundamentals
| Return On Equity | 0.0874 | ||||
| Return On Asset | 0.0355 | ||||
| Profit Margin | 0.11 % | ||||
| Operating Margin | 0.17 % | ||||
| Current Valuation | 6.33 B | ||||
| Shares Outstanding | 294.8 M | ||||
| Shares Owned By Insiders | 2.23 % | ||||
| Shares Owned By Institutions | 90.42 % | ||||
| Number Of Shares Shorted | 8.62 M | ||||
| Price To Earning | 48.17 X | ||||
| Price To Book | 3.05 X | ||||
| Price To Sales | 3.78 X | ||||
| Revenue | 1.83 B | ||||
| Gross Profit | 1.55 B | ||||
| EBITDA | 196.6 M | ||||
| Net Income | 207.76 M | ||||
| Cash And Equivalents | 1.53 B | ||||
| Cash Per Share | 4.77 X | ||||
| Total Debt | 189.94 M | ||||
| Debt To Equity | 0.07 % | ||||
| Current Ratio | 6.08 X | ||||
| Book Value Per Share | 7.48 X | ||||
| Cash Flow From Operations | 333.32 M | ||||
| Short Ratio | 3.93 X | ||||
| Earnings Per Share | 0.65 X | ||||
| Price To Earnings To Growth | 1.69 X | ||||
| Target Price | 26.74 | ||||
| Number Of Employees | 1.31 K | ||||
| Beta | 0.57 | ||||
| Market Capitalization | 6.92 B | ||||
| Total Asset | 2.94 B | ||||
| Retained Earnings | (173.35 M) | ||||
| Working Capital | 923.68 M | ||||
| Current Asset | 178.66 M | ||||
| Current Liabilities | 52.25 M | ||||
| Net Asset | 2.94 B |
About Exelixis Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Exelixis's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Exelixis using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Exelixis based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Exelixis
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Exelixis position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Exelixis will appreciate offsetting losses from the drop in the long position's value.Moving against Exelixis Stock
| 0.69 | ETON | Eton Pharmaceuticals Financial Report 9th of May 2024 | PairCorr |
| 0.64 | SBFMW | Sunshine Biopharma | PairCorr |
| 0.62 | EVOK | Evoke Pharma | PairCorr |
| 0.52 | EGRX | Eagle Pharmaceuticals | PairCorr |
| 0.51 | DVAX | Dynavax Technologies Financial Report 7th of May 2024 | PairCorr |
The ability to find closely correlated positions to Exelixis could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Exelixis when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Exelixis - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Exelixis to buy it.
The correlation of Exelixis is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Exelixis moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Exelixis moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Exelixis can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Exelixis Piotroski F Score and Exelixis Altman Z Score analysis. For more information on how to buy Exelixis Stock please use our How to buy in Exelixis Stock guide.Note that the Exelixis information on this page should be used as a complementary analysis to other Exelixis' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Complementary Tools for Exelixis Stock analysis
When running Exelixis' price analysis, check to measure Exelixis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Exelixis is operating at the current time. Most of Exelixis' value examination focuses on studying past and present price action to predict the probability of Exelixis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Exelixis' price. Additionally, you may evaluate how the addition of Exelixis to your portfolios can decrease your overall portfolio volatility.
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| CEOs Directory Screen CEOs from public companies around the world | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |
Is Exelixis' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Exelixis. If investors know Exelixis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Exelixis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.99) | Earnings Share 0.65 | Revenue Per Share 5.753 | Quarterly Revenue Growth 0.131 | Return On Assets 0.0355 |
The market value of Exelixis is measured differently than its book value, which is the value of Exelixis that is recorded on the company's balance sheet. Investors also form their own opinion of Exelixis' value that differs from its market value or its book value, called intrinsic value, which is Exelixis' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Exelixis' market value can be influenced by many factors that don't directly affect Exelixis' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Exelixis' value and its price as these two are different measures arrived at by different means. Investors typically determine if Exelixis is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Exelixis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.